Prime Minister Justin Trudeau announced last week federal investments for TRIUMF, Canada’s particle accelerator centre, to create a new life sciences facility called the Institute for Advanced Medical Isotopes (IAMI). Of the total $31.8 million required for construction, Ottawa will provide $10.2 million, British Columbia $12.2, TRIUMF $5.4 million, and the BC Cancer Foundation and UBC $2 million each. Situated on TRIUMF's campus, IAMI will advance research into life-saving medical isotopes and radiopharmaceuticals. The facility will include labs and a TR-24 medical cyclotron, one of the most technologically advanced commercial cyclotrons in the world. Among its many offerings, IAMI will provide a secure supply of important medical isotopes, contribute to next-generation cancer therapies, and accelerate global drug development by producing sought-after isotope-based radiotracers for gauging drug efficacy.